Acrivon Therapeutics, Inc.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

Director

$42.37M (1)

—

+$42.37M

9,366

0.0219%

$20.67K

—

PERCEPTIVE ADVISORS LLC entity

10% owner

$20.00M (1)

$3.76M (5)

+$16.24M

3,104,139

7.24%

$6.85M

+3.2%

Chione Ltd entity

10% owner

$5.00M (1)

$97.58K (5)

+$4.90M

3,848,632

8.98%

$8.49M

—

Blume-Jensen Peter

President and CEO

$82.12K (1)

$34.41K (3)

+$47.71K

2,615,911

6.10%

$5.77M

+125.0%

Devroe Eric

Chief Operating Officer

$17.22K (1)

$1.21K (1)

+$16.00K

146,349

0.3415%

$322.90K

+621.8%

Levy Adam D.

Chief Financial Officer

$15.00K (1)

$1.79K (1)

+$13.21K

66,008

0.1540%

$145.64K

+395.7%

Miller Mary

Chief Legal Officer

—

$1.38K (2)

−$1.38K

82,009

0.1914%

$180.94K

+102.8%

Gamelin Erick

Chief Development Officer

—

$804.00 (1)

−$804.00

52,592

0.1227%

$116.04K

—

Peterson Katharine

Chief Accounting Officer

—

$203.01 (1)

−$203.01

18,033

0.0421%

$39.79K

+273.2%

Masson Kristina

EVP - Business Operations

—

2,687,343

6.27%

$5.93M

+130.5%

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

10% owner

—

888,130

2.07%

$1.96M

—

Mirza Mansoor Raza

Chief Medical Officer

—

38,817

0.0906%

$85.65K

—

Levin Michaela

Chief Business Officer

—

30,000

0.0700%

$66.19K

—

Holm-Jorgensen Rasmus

Chief Financial Officer

—

26,088

0.0609%

$57.56K

—

DiRocco Derek

Director

—

9,366

0.0219%

$20.67K

—

Palani Santhosh

Director

—

9,366

0.0219%

$20.67K

—

Magovcevic-Liebisch Ivana

Director

—

9,366

0.0219%

$20.67K

—

TOMSICEK MICHAEL JOHN

Director

—

9,366

0.0219%

$20.67K

—

Shacham Sharon

Director

—

9,366

0.0219%

$20.67K

—

BAUM CHARLES M

Director

—

9,366

0.0219%

$20.67K

—

Acrivon Therapeutics, Inc.

By person

Individual transactions

What was left out